Pfizer, Inc.

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse 04:01:07 2024-05-21 pm EDT 5-day change 1st Jan Change
28.56 USD +0.11% Intraday chart for Pfizer, Inc. +0.63% -0.80%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sector Update: Health Care Stocks Advance Late Afternoon MT
China-Based Asymchem Laboratories Will Operate Former Pfizer Manufacturing Facility in UK DJ
Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon MT
Sector Update: Health Care MT
Senate Finance Committee Chairman Questions Pfizer's Tax Practices MT
Global markets live: Apple, Tesla, Pfizer, AstraZeneca, Microsoft... Our Logo
DA Davidson Raises Price Target on Pfizer to $35 From $30, Maintains Buy/Add Rating MT
Correction: AstraZeneca Ordered to Pay $108 Million to Pfizer for Patent Violations MT
AstraZeneca Ordered to Pay $108 Million to Pfizer for Patent Violations MT
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial RE
Sector Update: Health Care Stocks Mixed Late Afternoon MT
Sector Update: Health Care Stocks Softer Friday Afternoon MT
Sector Update: Health Care MT
Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech MT
Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech MT
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program MT
Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot, FT reports RE
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program MT
Investor Whitefort urges Arbutus Biopharma to halt stock sales, find partner RE
GSK sells remaining Haleon stake for GBP1.25 billion AN
GSK raises $1.5 bln from sale of remaining Haleon stake RE
GSK to Sell Remaining Stake in Haleon Valued at Around $1.27 Billion -- Update DJ
Global markets live: Cisco, EasyJet, Roche, Netflix, Amazon... Our Logo
Sector Update: Health Care Stocks Steady Premarket Thursday MT
Sector Update: Health Care MT
Chart Pfizer, Inc.
More charts
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.53 USD
Average target price
31.94 USD
Spread / Average Target
+11.95%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW